Thursday, October 16, 2025

The Daily Chronicle

Bringing you the world's news since 1892
| health | brightspring health services s...

BrightSpring Health Services Set to Join S&P SmallCap 600

BrightSpring Health Services Set to Join S&P SmallCap 600

NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 20. S&P 500 constituent Huntington...

Read Full Article

Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025

Peer Reviewed Publication Provides Evidence for Iron Dysregulation as a Driver of Dry AMD/GA and the Potential of Transferrin to Restore Iron Balance, Reinforcing PulseSight’s Therapeutic Strategy for PST-611

Argentina gets $20B while health care suffers

Argentina gets $20B while health care suffers

Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference

Pancreatic Endocrine Tumor Market Set to Witness Significant Growth During the Forecast Period (2025–2034) Owing to the Expected Launch of Therapies | DelveInsight

Column: Allergies aren't just for summer

Column: Allergies aren't just for summer

Quanta Therapeutics Announces First Clinical Data Presentation for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

9 fall casseroles so good you’ll crave them always

Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology

Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology

4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation

Vasa Therapeutics Receives FDA IND Clearance to Advance Novel Small Molecule VS-041 for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)

Vasa Therapeutics Receives FDA IND Clearance to Advance Novel Small Molecule VS-041 for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)

More Texas kindergarteners are coming to school without measles vaccination proof or exemptions - The Texas Tribune

I’m a spine surgeon — this is absolutely the worst thing you can do for your neck and back

I’m a spine surgeon — this is absolutely the worst thing you can do for your neck and back

bioLytical's iStatis Syphilis Antibody Test Now Included in the Australian Register of Therapeutic Goods (ARTG)

Death rates are rising in young adults in Eastern Europe - politico.eu

Mississippi hospital recognized nationally and other health care news

Mississippi hospital recognized nationally and other health care news

A longevity expert says stress accelerates how fast you age—these are the two things he does to reduce his stress levels - Fit&Well